Has Huaguang Qu, MD received payments from drug or device companies?

Yes. Drug and device makers reported $355,816 in general payments to Huaguang Qu, MD across 705 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Huaguang Qu, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Huaguang Qu, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Huaguang Qu, MD

Physical Medicine & Rehabilitation · Chalfont, PANPI 1952563660

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $252,713 of the $355,816 with a category attached, or 71.0%. Boston Scientific accounts for 75.4% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2022 at $78,734 and has fallen 99.7% since, to $205 in 2025. Among physical medicine & rehabilitation clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$355,816in general payments, 2019–2025

Across 705 payments — averaging $504.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$268K
Vertos Medical, Inc.$56K
Vertiflex, Inc.$11K
Flowonix Medical Incorporated$10K
Foundation Fusion Solutions, LLC$6K
Relievant Medsystems, Inc.$1K
plus $3K from 15 others

$70,085in research payments, 2019–2025

Across 82 payments — averaging $854.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Vertos Medical, Inc.$65K
Stryker$6K

What the payments were for

Consulting fees$56,18116%
Speaking & faculty fees$252,71371%
Travel & lodging$26,9978%
Food & beverage$19,9266%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	422	$268,391
Vertos Medical, Inc.	173	$55,797
Vertiflex, Inc.	19	$10,634
Flowonix Medical Incorporated	3	$10,456
Foundation Fusion Solutions, LLC	18	$6,060
Relievant Medsystems, Inc.	15	$1,408
Abbott	15	$1,249
Surgentec	1	$463
Painteq LLC	4	$331
AbbVie(2 entities)	18	$317
Nalu Medical, Inc.	2	$141
Stryker	1	$109
Electronic Waveform Lab, Inc.	1	$99
Spinal Simplicity, LLC	2	$93
Stimwave Technologies Incorporated	1	$74
Collegium Pharmaceutical, Inc.	3	$59
Medtronic	2	$43
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$37
Scilex Pharmaceuticals Inc.	1	$22
SPR Therapeutics, Inc	1	$21
Amgen	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

mild Device Kit$53,478
Superion Indirect Decompression System$50,069
GENERAL PAIN MANAGEMENT$29,637
WaveWriter Alpha Prime 16$26,708
VERIFLEX$26,250
WAVEWRITER ALPHA$24,552
SUPERION$18,001
SPECTRA WAVEWRITER$17,920
Prometra II$10,456
Superion ISS$10,121
GENERAL - THERAPIES$9,730
Intracept$2,428
GENERAL BRADY$1,409
Proclaim Family of SCS IPGs$850
3D GraftRasp System$463
PAINTEQ$158
Nalu Neurostimulation System$125
Watchman$124

How this compares

$355,816 in reported general payments places this provider in the 95th percentile of 550 physical medicine & rehabilitation providers in Pennsylvania.

See all physical medicine & rehabilitation providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$280,874

Medicare patients

487

Services billed

11,882

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cephalexin	15	$57

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Chalfont

Robert KellyChalfont$7K
Bruce ZhangChalfont$4K
Jeffery RoweKing Of Prussia$1.9M
Michael SaulinoElkins Park$425K
Alberto EsquenaziPhiladelphia$305K
Mitchell PaulinPaoli$229K
Kimberly HeckertPhiladelphia$119K
David LichtenReading$117K
Gay WilcherRidley Park$81K
Jessica MulhernPaoli$79K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →